The PPARG high expression in renal and urothelial cancer was associated with favorable life expectancy and unfavorable life expectancy in liver cancer (https://www.proteinatlas.org/ENSG00000132170-PPARG/pathology, accessed on 12 February 2024) PPARG SNPs have been associated with cancer risk, in particular for BC, ovarian carcinoma, follicular lymphoma, and colorectal cancer [92,93,94]. The gene discussed is PPARG; the disease is liver cancer.